Lung cancer is one of the most intractable diseases with high incidence and mortality worldwide. Adenylate cyclase-associated protein 1 (CAP1), a well-known actin depolymerization factor, is recently reported to be an oncogene accelerating cancer cell proliferation. However, the physiological significance of CAP1 in lung cancer is incompletely understood and the novel functions of CAP1 in transcriptional regulation remain unknown. Here we found that CAP1 was highly expressed in lung cancer tissues and cells, which was also negatively associated with prognosis in lung cancer patients. Moreover, CAP1 promoted A549 cells proliferation by promoting protein synthesis to accelerate cell cycle progression. Mechanistically, we revealed that CAP1 facilitated cyclin-dependent kinase 9 (CDK9)-mediated RNA polymerases (Pol) II-Ser2 phosphorylation and subsequent transcription elongation, and CAP1 performed its function in this progress depending on its actin-depolymerization activity in nucleoplasm. Furthermore, our in vivo findings confirmed that CAP1-promoted A549 xenograft tumor growth was associated with CDK9-mediated Pol II-Ser2 phosphorylation. Our study elucidates a novel role of CAP1 in modulating transcription by promoting polymerase II phosphorylation and suggests that CAP1 is a newly identified biomarker for lung cancer treatment and prognosis prediction.
Subscribe to Journal
Get full journal access for 1 year
only $7.98 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;0:1–14.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.
Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 2011;32:703–40.
Freeman NL, Chen Z, Horenstein J, Weber A, Field J. An actin monomer binding activity localizes to the carboxyl-terminal half of the Saccharomyces cerevisiae cyclase-associated protein. J Biol Chem. 1995;270:5680–5.
Zhang H, Ghai P, Wu H, Wang C, Field J, Zhou GL. Mammalian adenylyl cyclase-associated protein 1 (CAP1) regulates cofilin function, the actin cytoskeleton, and cell adhesion. J Biol Chem. 2013;288:20966–77.
Xie S, Liu Y, Li X, Tan M, Wang C, Field J, et al. Phosphorylation of the cytoskeletal protein CAP1 regulates non-small cell lung cancer survival and proliferation by GSK3β. J Cancer. 2018;9:2825–33.
Tan M, Song X, Zhang G, Peng A, Li X, Li M, et al. Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer. Oncol Rep. 2013;30:1639–44.
Lee MJ, Yaffe MB. Protein regulation in signal transduction. Cold Spring Harb Perspect Biol. 2016;8:a005918
Fan H, Conn AB, Williams PB, Diggs S, Hahm J, Gamper HB, et al. Transcription-translation coupling: direct interactions of RNA polymerase with ribosomes and ribosomal subunits. Nucleic Acids Res. 2017;45:11043–55.
Bock FJ, Todorova TT, Chang P. RNA regulation by poly(ADP-ribose) polymerases. Mol Cell. 2015;58:959–69.
Arimbasseri AG, Maraia RJ. RNA polymerase III advances: structural and tRNA functional views. Trends Biochem Sci. 2016;41:546–59.
Zhang Y, Najmi SM, Schneider DA. Transcription factors that influence RNA polymerases I and II: to what extent is mechanism of action conserved? Biochim Biophys Acta Gene Regul Mech. 2017;1860:246–55.
Wang J, Zhao S, Wei Y, Zhou Y, Shore P, Deng W, et al. Differentially modulates RNA polymerase III gene transcription in transformed cell lines. J Biol Chem. 2016;291:25239–46.
Srivastava R, Ahn SH. Modifications of RNA polymerase II CTD: Connections to the histone code and cellular function. Biotechnol Adv. 2015;33:856–72.
Proudfoot NJ. Transcriptional termination in mammals: stopping the RNA polymerase II juggernaut. Science. 2016;352:aad9926.
Buratowski S. Progression through the RNA polymerase II CTD cycle. Mol Cell. 2009;36:541–6.
Lu H, Yu D, Hansen AS, Ganguly S, Liu R, Heckert A, et al. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II. Nature. 2018;558:318–23.
Hu P, Wu S, Hernandez N. A role for beta-actin in RNA polymerase III transcription. Genes Dev. 2004;18:3010–5.
Yoo Y, Wu X, Guan JL. A novel role of the actin-nucleating Arp2/3 complex in the regulation of RNA polymerase II-dependent transcription. J Biol Chem. 2007;282:7616–23.
Ye J, Zhao J, Hoffmann-Rohrer U, Grummt I. Nuclear myosin I acts in concert with polymeric actin to drive RNA polymerase I transcription. Genes Dev. 2008;22:322–30.
Vieu E, Hernandez N. Actin’s latest act: polymerizing to facilitate transcription? Nat Cell Biol. 2006;8:650–1.
Almuzzaini B, Sarshad AA, Rahmanto AS, Hansson ML, Von Euler A, Sangfelt O, et al. In β-actin knockouts, epigenetic reprogramming and rDNA transcription inactivation lead to growth and proliferation defects. FASEB J. 2016;30:2860–73.
Ho CK, Shuman S. Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol Cell. 1999;3:405–11.
O’Brien T, Hardin S, Greenleaf A, Lis JT. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature. 1994;370:75–7.
Lu H, Zawel L, Fisher L, Egly JM, Reinberg D. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature. 1992;358:641–5.
Komarnitsky P, Cho EJ, Buratowski S. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 2000;14:2452–60.
Percipalle P, Visa N. Molecular functions of nuclear actin in transcription. J Cell Biol. 2006;172:967–71.
Fomproix N, Percipalle P. An actin-myosin complex on actively transcribing genes. Exp Cell Res. 2004;294:140–8.
Gieni RS, Hendzel MJ. Actin dynamics and functions in the interphase nucleus: moving toward an understanding of nuclear polymeric actin. Biochem Cell Biol. 2009;87:283–306.
Serebryannyy LA, Parilla M, Annibale P, Cruz CM, Laster K, Gratton E, et al. Persistent nuclear actin filaments inhibit transcription by RNA polymerase II. J Cell Sci. 2016;129:3412–25.
Qi T, Tang W, Wang L, Zhai L, Guo L, Zeng X. G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb). J Biol Chem. 2011;286:15171–81.
Percipalle P. Co-transcriptional nuclear actin dynamics. Nucleus. 2013;4:43–52.
Obrdlik A, Percipalle P. The F-actin severing protein cofilin-1 is required for RNA polymerase II transcription elongation. Nucleus. 2011;2:72–9.
Zhou Q, Li T, Price DH. RNA polymerase II elongation control. Annu Rev Biochem. 2012;81:119–43.
Brar GA, Weissman JS. Ribosome profiling reveals the what, when, where and how of protein synthesis. Nat Rev Mol Cell Biol. 2015;16:651–64.
Van Der Kelen K, Beyaert R, Inzé D, De Veylder L. Translational control of eukaryotic gene expression. Crit Rev Biochem Mol Biol. 2009;44:143–68.
Schmidt EK, Clavarino G, Ceppi M, Pierre P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods. 2009;6:275–7.
Bogomoletz WV, Pourny C, Didier B. Argyrophilic nuclear organiser region counts in locally advanced breast carcinoma treated by chemotherapy before surgery. Eur J Cancer. 1990;26:1042–4.
Serin G, Joseph G, Faucher C, Ghisolfi L, Bouche G, Amalric F, et al. Localization of nucleolin binding sites on human and mouse pre-ribosomal RNA. Biochimie. 1996;78:530–8.
Philimonenko VV, Zhao J, Iben S, Dingová H, Kyselá K, Kahle M, et al. Nuclear actin and myosin I are required for RNA polymerase I transcription. Nat Cell Biol. 2004;6:1165–72.
Riss TL, Moravec RA, Niles AL. Cytotoxicity testing: measuring viable cells, dead cells, and detecting mechanism of cell death. Methods Mol Biol. 2011;740:103–14.
Chen F, Chen X, Shilatifard A. Stably paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor triptolide. Genes Dev. 2015;29:39–47.
Gilchrist D, Nechaev S, Lee C, Ghosh S, Collins J, Li L, et al. NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly. Genes Dev. 2008;22:1921–33.
Yamaguchi K, Lantowski A, Dannenberg A, Subbaramaiah K. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. J Biol Chem. 2005;280:32569–77.
Smith E, Winter B, Eissenberg J, Shilatifard A. Regulation of the transcriptional activity of poised RNA polymerase II by the elongation factor ELL. PNAS. 2008;105:8575–9.
Pawlus M, Wang L, Murakami A, Dai G, Hu C. STAT3 or USF2 contributes to HIF target gene specificity. PLoS One. 2013;8:e72358.
Wu L, Pan J, Thoroddsen V, Wysong DR, Blackman RK, Bulawa CE, et al. Novel small-molecule inhibitors of RNA polymerase III. Eukaryot Cell. 2003;2:256–64.
Yee NS, Zhou W, Chun SG, Liang IC, Yee RK. Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer. Biol Open. 2012;1:295–307.
Bertling E, Hotulainen P, Mattila PK, Matilainen T, Salminen M, Lappalainen P. Cyclase-associated protein 1 (CAP1) promotes cofilin-induced actin dynamics in mammalian nonmuscle cells. Mol Biol Cell. 2004;15:2324–34.
Hofmann WA, Stojiljkovic L, Fuchsova B, Vargas GM, Mavrommatis E, Philimonenko V, et al. Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nat Cell Biol. 2004;6:1094–101.
Moriyama K, Yahara I. Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover. J Cell Sci. 2002;115:1591–601.
Kolegova ES, Kakurina GV, Kondakova IV, Dobrodeev AY, Kostromitskii DN, Zhuikova LD. Adenylate cyclase-associated protein 1 and cofilin in progression of non-small cell lung cancer. Bull Exp Biol Med. 2019;167:393–5.
White-Gilbertson S, Kurtz DT, Voelkel-Johnson C. The role of protein synthesis in cell cycling and cancer. Mol Oncol. 2009;3:402–8.
Liu Y, Cui X, Hu B, Lu C, Huang X, Cai J, et al. Upregulated expression of CAP1 is associated with tumor migration and metastasis in hepatocellular carcinoma. Pathol Res Pract. 2014;210:169–75.
Blank HM, Maitra N, Polymenis M. Lipid biosynthesis: When the cell cycle meets protein synthesis? Cell Cycle. 2017;16:905–6.
Hasan R, Zhou GL. The cytoskeletal protein cyclase-associated protein 1 (CAP1) in breast cancer: context-dependent roles in both the invasiveness and proliferation of cancer cells and underlying cell signals. Int J Mol Sci. 2019;20:2653
Pérez-Ortín J, Alepuz P, Chávez S, Choder M. Eukaryotic mRNA decay: methodologies, pathways, and links to other stages of gene expression. J Mol Biol. 2013;425:3750–75.
de Falco G, Giordano A. CDK9 (PITALRE): a multifunctional cdc2-related kinase. J Cell Physiol. 1998;177:501–6.
Holmberg Olausson K, Nistér M, Lindström M. Loss of nucleolar histone chaperone NPM1 triggers rearrangement of heterochromatin and synergizes with a deficiency in DNA methyltransferase DNMT3A to drive ribosomal DNA transcription. J Biol Chem. 2014;289:34601–19.
Hoeffer CA, Cowansage KK, Arnold EC, Banko JL, Moerke NJ, Rodriguez R, et al. Inhibition of the interactions between eukaryotic initiation factors 4E and 4G impairs long-term associative memory consolidation but not reconsolidation. PNAS. 2011;108:3383–8.
Liang H, Chen X, Yin Q, Ruan D, Zhao X, Zhang C, et al. PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription. Nat Commun. 2017;8:14771.
This work was supported by National Natural Science Foundation of China (Grant No. 81874357) and the Youth Talent Project of Army Medical University (Grant No. 2019R050).
Conflict of interest
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhang, Q., Tang, Q., Liu, W. et al. Novel role of CAP1 in regulation RNA polymerase II-mediated transcription elongation depends on its actin-depolymerization activity in nucleoplasm. Oncogene 40, 3492–3509 (2021). https://doi.org/10.1038/s41388-021-01789-3